LUNG CANCER SURGERY MARKET ANALYSIS

Lung Cancer Surgery Market, By Product Type (Surgical Instruments, Monitoring & Visualizing System, Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems and Others), By Surgery Type (Open Surgery, Minimally Invasive Surgery), By Procedure (Lobectomy, Segmentectomy/Wedge Resection, Pneumonectomy, Sleeve Resection, Extended Resection), By Cancer Stage (Early-Stage, Advanced-Stage), By End user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments

New product launches

In May 2022, Olympus Corporation, manufacturer of optical and digital precision technology, launched the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope. The BF-UC190F is a new generation of EBUS bronchoscope that offers improved image quality and navigation capabilities. It is designed to help surgeons better visualize and biopsy lung cancer lesions.
In February 2022, Intuitive Surgical Inc., a company which develops, manufactures, and markets products that enable physicians and healthcare providers, acquired Orpheus Medical. Orpheus Medical is a developer of robotically-assisted lung biopsy systems. The acquisition of Orpheus Medical will give Intuitive Surgical a new platform for developing robotically-assisted lung cancer surgery systems.
In December 2020, Medtronic, a medical device company, announced the launch of Tri-Staple EEA Circular Stapler in India. The new Tri-Staple Technology comprises a sloped cartridge face that delivers less stress on tissue. It also offers consistent performance over a broad range of tissue thicknesses and allows for greater perfusion into the staple line.

Acquisition and partnerships

In February 2023, Intuitive Surgical Inc., a company which develops, manufactures, and markets products that enable physicians and healthcare providers, acquired Auris Health Inc., a medical device company, Auris Health is a developer of robotically-assisted bronchoscopy systems. The acquisition of Auris Health will give Intuitive Surgical a new platform for developing robotically-assisted lung cancer surgery systems.
In December 2022, Clinithink, a technology company, announced partnership with AstraZeneca, a biopharmaceutical company, to detect early stage lung cancer
In March 2021, Agilent Technologies Inc., a provider of instruments, reagents, software, services, and consumables, announced it had entered into a definitive agreement to acquire Resolution Bioscience Inc., a company focused on the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. The acquisition complements and expands Agilent Technologies Inc’s., capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further serve the needs of the fast-growing precision medicine market.